Condition

Leukemia, Myeloid, Acute clinical trials and research

• 19Clinical trials
• 30Countries

Newest Leukemia, Myeloid, Acute clinical trials

All recruiting trials (19)

• Electronic mindfulness-based music therapy for patients receiving stem cell transplantation

  This trial tests an eHealth mindfulness-based music therapy to see if it improves quality of life and reduces symptoms for adults undergoing stem cell transplantation.

  Recruiting University of Miami · Miami, Florida · NCT07469592

• Orca-T after reduced-intensity or nonmyeloablative conditioning for adults with AML or MDS

  This trial will test whether Orca-T, a donor-derived stem cell and T-cell therapy, is safe and helps adults with acute myeloid leukemia or myelodysplastic syndrome who are receiving reduced-intensity or nonmyeloablative allogeneic stem cell transplants.

  Recruiting at 6 sites Phase 2 Orca Biosystems, Inc. · Los Angeles, California and 5 other locations · NCT07216443

• Registry for patients with myelodysplastic syndromes and therapy-related acute myeloid leukemia

  This study is collecting health information from adults with myelodysplastic syndromes and therapy-related acute myeloid leukemia to better understand these conditions and improve patient care.

  Recruiting Groupe Francophone des Myelodysplasies · Rouen · NCT06956755

• Bleximenib added to venetoclax and azacitidine for newly diagnosed NPM1- or KMT2A-mutated AML

  This trial will test whether adding bleximenib to venetoclax plus azacitidine helps people with newly diagnosed AML that has NPM1 or KMT2A mutations who cannot have intensive chemotherapy.

  Recruiting at 270 sites Phase 3 Janssen Research & Development, LLC · Birmingham, Alabama and 269 other locations · NCT06852222

• Genetic analysis in women with metastatic ovarian cancer during PARP inhibitor treatment

  This study is testing how PARP inhibitor treatment affects the genes and blood cells of women with metastatic ovarian cancer to see if it leads to any serious side effects.

  Recruiting European Institute of Oncology · Milan · NCT06785077

• Combining Venetoclax with Intensive Therapy for Acute Myeloid Leukemia Patients

  This study is testing if adding a drug called Venetoclax to standard chemotherapy can help newly diagnosed acute myeloid leukemia patients who aren't responding well to their initial treatment.

  Recruiting Affiliated Hospital of Nantong University · Nantong, Jiangsu · NCT06643962

• Genetic factors affecting treatment response in acute myeloid leukemia

  This study is testing how certain genetic differences affect the side effects and success of a treatment for people newly diagnosed with acute myeloid leukemia who are receiving azacitidine and venetoclax.

  Recruiting at 2 sites Wake Forest University Health Sciences · Charlotte, North Carolina and 1 other locations · NCT06580106

• Testing BH-30236 for relapsed or refractory acute myelogenous leukemia and higher-risk myelodysplastic syndrome

  This study is testing a new drug called BH-30236 to see if it can help adults with relapsed or hard-to-treat acute myelogenous leukemia or higher-risk myelodysplastic syndrome.

  Recruiting at 13 sites Phase 1 BlossomHill Therapeutics · Duarte, California and 12 other locations · NCT06501196

• Genetically modified T cells for treating relapsed or refractory acute myeloid leukemia

  This study is testing a new treatment that uses specially modified T cells to see if it can help people with relapsed or hard-to-treat acute myeloid leukemia.

  Recruiting Phase 1/2 Miltenyi Biomedicine GmbH · Leiden · NCT06424340

• CD70-targeted CAR-T therapy for certain leukemias

  This trial tests a specially engineered T-cell therapy to see if it can help people with CD70-expressing leukemias that have come back or not responded to standard treatment.

  Recruiting at 2 sites Phase 1 Baylor College of Medicine · Houston, Texas and 1 other locations · NCT06345027

• BG1805 injection for treating relapsed or refractory acute myeloid leukemia

  This study is testing a new injection called BG1805 to see if it can help people with relapsed or refractory acute myeloid leukemia feel better.

  Recruiting at 3 sites Phase 1/2 Guangzhou Bio-gene Technology Co., Ltd · Guangzhou, Guangdong and 2 other locations · NCT06118788

• Examining the safety of ziftomenib combinations for patients with relapsed acute myeloid leukemia

  This study is testing if combining ziftomenib with standard treatments can safely help people with relapsed acute myeloid leukemia feel better and improve their chances of recovery.

  Recruiting at 43 sites Phase 1 Kura Oncology, Inc. · Gilbert, Arizona and 44 other locations · NCT06001788

• New treatment combining stem cell transplant and CAR T-cell therapy for acute leukemia

  This study is testing a new treatment that combines a stem cell transplant with special CAR T-cells to see if it can help people with hard-to-treat acute myeloid leukemia.

  Recruiting Phase 1 University of Pennsylvania · Philadelphia, Pennsylvania · NCT05945849

• Chidamide treatment to prevent leukemia recurrence after stem cell transplant

  This study is testing if a medication called chidamide can help prevent leukemia from coming back in patients with high-risk acute myeloid leukemia after they have a stem cell transplant.

  Recruiting Phase 1/2 Sichuan University · Chengdu, Sichuan · NCT05682755

• Treatment for elderly patients with newly diagnosed acute myeloid leukemia

  This study is testing a new treatment plan for older patients with newly diagnosed acute myeloid leukemia to see if it can help them do better without the harsh side effects of standard chemotherapy.

  Recruiting Phase 2 The First Affiliated Hospital of Xiamen University · Xiamen, Fujian · NCT05603884

• Combining Venetoclax, Chidamide, and Azacitidine for treating relapsed AML

  This study is testing a new combination of three drugs to see if it can help people with relapsed acute myeloid leukemia feel better and achieve longer-lasting results.

  Recruiting Phase 2 The First Affiliated Hospital of Xiamen University · Xiamen, Fujian · NCT05305859

• Post-transplant azacitidine plus chidamide to prevent relapse in high-risk acute myeloid leukemia

  This tests whether giving azacitidine together with chidamide after an allogeneic stem-cell transplant can help prevent relapse in adults (18–60) with high‑risk acute myeloid leukemia.

  Recruiting Phase 1/2 Zhujiang Hospital · Guanzhou, Guandong · NCT05270200

• Testing Enzomenib for patients with relapsed or refractory acute leukemia

  This study is testing a new drug called Enzomenib to see if it can help adults with relapsed or hard-to-treat acute leukemia feel better.

  Recruiting at 80 sites Phase 1/2 Sumitomo Pharma America, Inc. · Newport Beach, California and 103 other locations · NCT04988555

• Evaluating the safety and effectiveness of tuspetinib in patients with relapsed or refractory acute myeloid leukemia

  This study is testing a new drug called tuspetinib to see if it can safely help people with relapsed or hard-to-treat types of leukemia and related blood disorders.

  Recruiting at 10 sites Phase 1/2 Aptose Biosciences Inc. · Birmingham, Alabama and 33 other locations · NCT03850574

Related topics

Quick answers

How many Leukemia, Myeloid, Acute clinical trials are recruiting right now?

19, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 30 countries. The most sites are in United States (10 trials), China (7 trials), Italy (4 trials), Spain (4 trials), France (3 trials). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1/2: 6, Phase 1: 4, Phase 2: 3, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →